{
    "2021-01-25": [
        [
            {
                "time": "",
                "original_text": "【浙商医药|周报】抱团与分化下，寻找长期价值",
                "features": {
                    "keywords": [
                        "抱团",
                        "分化",
                        "长期价值"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药外包行业周报-CXO：是 但不仅仅是业绩超预期",
                "features": {
                    "keywords": [
                        "CXO",
                        "业绩超预期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药外包"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：2020Q4公募基金重仓医药持仓几何？继续强调Q1医药躁动期",
                "features": {
                    "keywords": [
                        "公募基金",
                        "重仓医药",
                        "Q1躁动期"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗健康行业2020年报业绩预告：四季度业绩加速恢复",
                "features": {
                    "keywords": [
                        "年报",
                        "业绩加速恢复"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【异动股】泰格医药(03347-HK)涨4.39%",
                "features": {
                    "keywords": [
                        "异动股",
                        "泰格医药",
                        "涨4.39%"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}